- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 471/10 - Spiro-condensed systems
Patent holdings for IPC class C07D 471/10
Total number of patents in this class: 2145
10-year publication summary
|
144
|
129
|
145
|
169
|
172
|
176
|
196
|
211
|
201
|
58
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 5080 |
60 |
| Merck Sharp & Dohme LLC | 3689 |
52 |
| F. Hoffmann-La Roche AG | 7958 |
51 |
| Novartis AG | 11238 |
49 |
| Merck Patent GmbH | 5909 |
47 |
| Pfizer Inc. | 3322 |
33 |
| Hoffmann-La Roche Inc. | 3060 |
32 |
| Boehringer Ingelheim International GmbH | 4629 |
32 |
| Syngenta Participations AG | 4970 |
32 |
| Janssen Pharmaceutica N.V. | 3839 |
23 |
| H. Lundbeck A/S | 1252 |
23 |
| Celgene Quanticel Research, Inc. | 167 |
22 |
| Incyte Corporation | 918 |
22 |
| Takeda Pharmaceutical Company Limited | 2961 |
21 |
| Merck Sharp & Dohme Corp. | 2247 |
20 |
| Astellas Pharma Inc. | 1145 |
20 |
| The Regents of the University of Michigan | 4409 |
19 |
| Heptares Therapeutics Limited | 225 |
19 |
| Incyte Holdings Corporation | 609 |
18 |
| Arvinas Operations, Inc. | 165 |
18 |
| Other owners | 1532 |